Gelonghui, January 8 | In the afternoon, several listed companies issued announcements. The details are as follows: ① Xidian Pharmaceutical: The company recently received the “Notice of Acceptance” issued by the State Drug Administration for the registration and marketing of drugs produced domestically produced in the country for oral solution of protein and iron succinate. Protein iron succinate oral solution is used for absolute and relative iron deficiency anemia such as hidden or overt iron deficiency anemia due to insufficient iron intake or absorption disorder, acute or chronic blood loss, and infection, and anemia during pregnancy and breastfeeding. ② Chuanheng Co., Ltd.: The company plans to increase the capital of its wholly-owned subsidiary Chuanheng Ecology by 50 million yuan to meet operating and construction capital requirements. Chuanheng Ecology is mainly responsible for the company's technology incubation site. In addition, the company plans to jointly increase the capital of Sichuan Wanpeng Times Technology Co., Ltd. (“Wanpeng Times”) with Blue Sword Investment and others, with a total capital increase of 100 million yuan, of which the company has pledged a capital increase of 30 million yuan. After the capital increase was completed, there was no change in the shareholding ratio of the parties in Wanpeng Era, and the company held 30% of the shares. ③ Xinghua Co., Ltd.: Xinghua Chemical, a wholly-owned subsidiary, has completed all maintenance plans except for the Beitao air separation plant and resumed single operation on January 6. During the major maintenance period, the Xinghua Chemical Beitao air separation plant discovered that the distillation tower sieve plate was seriously damaged and needed to urgently purchase spare parts from the equipment manufacturer. Due to the long production and delivery cycle of spare parts for the device, it is expected that the double set will resume operation in February 2024. ④ Yucai Resources: The company was rated as a national green factory. ⑤ China Green Power: The company's total loan balance at the end of 2023 was 43.88 billion yuan, with cumulative additional loans of 25.873 billion yuan in 2023, accounting for 146.33% of the net assets covered by the consolidated statement at the end of 2022. The company's new loans are mainly new bank loans and bonds, which are used for project construction, repayment of maturing debts, and daily operating capital requirements, and will not have a significant adverse impact on the company's operating conditions and solvency. The company's operation is steady, the profit situation is good, and the operating conditions of various businesses are normal. ⑥ Haineng Industrial: Zhou Hongliang, the controlling shareholder and actual controller of the company, transferred a total of 645,000 “Haineng Convertible Bonds” through the Shenzhen Stock Exchange system through bulk transactions between December 18, 2023 and January 5, 2024, accounting for 10.75% of the total amount issued. After this change, Zhou Hongliang held approximately 1.6611 million “Haineng Convertible Bonds”, accounting for 27.68% of the total amount issued.